0	article-title	article-title	1	The RNA-Binding Protein KSRP Promotes Decay of beta-Catenin mRNA and Is Inactivated by PI3K-AKT Signaling
1	abstract	abstract	0	beta-catenin plays an essential role in several biological events including cell fate determination, cell proliferation, and transformation. Here we report that beta-catenin is encoded by a labile transcript whose half-life is prolonged by Wnt and phosphatidylinositol 3-kinase-AKT signaling. AKT phosphorylates the mRNA decay-promoting factor KSRP at a unique serine residue, induces its association with the multifunctional protein 14-3-3, and prevents KSRP interaction with the exoribonucleolytic complex exosome. This impairs KSRP's ability to promote rapid mRNA decay. Our results uncover an unanticipated level of control of beta-catenin expression pointing to KSRP as a required factor to ensure rapid degradation of beta-catenin in unstimulated cells. We propose KSRP phosphorylation as a link between phosphatidylinositol 3-kinase-AKT signaling and beta-catenin accumulation.
3	abstract	abstract	0	Author Summary During mammalian development and adulthood, beta-catenin regulates the transcription of a family of genes with multiple essential roles in cell proliferation and differentiation. beta-catenin also plays a role in cancer when it carries mutations that result in uncontrolled beta-catenin function. Here, we report that the lifetime of the beta-catenin-encoding transcript is under regulatory control. We show that specific cellular signals relevant to proper mammalian development and implicated in tumor formation can prolong beta-catenin transcript half-life, leading to the accumulation of beta-catenin protein. We identify a molecular mechanism for this prolongation by showing that a protein factor responsible for beta-catenin transcript instability (and thus degradation) is impaired by phosphorylation, a chemical modification. When this factor is impaired, beta-catenin mRNA and protein accumulate. Our results point to an unanticipated control of beta-catenin levels through regulation of its transcript half-life in response to signals related to proliferation and differentiation.
6	abstract	abstract	0	The authors show that the half-life of beta-catenin mRNA is prolonged by PI3K-AKT signaling, revealing a new level of control on beta-catenin.
9	s1	N/A	1	Introduction
10	s1	N/A	0	The half-life (t(1/2)) of mRNAs is regulated in a complex fashion in response to external stimuli. Whereas transcripts containing the AU-rich element (ARE) are labile, activation of signal transduction pathways induces their stabilization    . It is now clear that mRNA decay regulation by different signals makes a huge contribution to the global control of gene expression    . AREs, located in the 3' untranslated region (3' UTR) of many short-lived transcripts, promote mRNA deadenylation and decapping followed by degradation of the mRNA body      . Mammalian ARE-containing transcripts are thought to be deadenylated by at least one of the seven known deadenylases and degraded mainly by the exosome, a multiprotein complex containing 3'-5' exonucleases      . A relevant role in mRNA decay has been recently demonstrated for the 5'-3' exonuclease Xrn1    . ARE-binding proteins (ARE-BPs) are trans-acting factors responsible for the decay control of labile mRNAs    . Some ARE-BPs are decay-promoting factors (TTP, BRF1, KSRP), and others, such as HuR, are stabilizing factors, whereas AUF1 promotes either decay or stabilization depending on the cellular context or its isoform expression profile    . According to the recently proposed recruitment model, destabilizing ARE-BPs interact with AREs and recruit the degradation machinery to the mRNA      . The ARE-BP KSRP, containing four contiguous K homology (KH) motifs that recognize the AREs and interact with the mRNA degradation machinery, promotes rapid decay of several ARE-containing mRNAs both in vitro and in vivo      .
11	s1	N/A	0	Activation of the stress-responsive c-Jun N-terminal kinase    , p38 MAP kinase      , MAPKAPK2        , phosphatidylinositol 3-kinase (PI3K)-AKT        , and Wnt/beta-catenin signaling      was shown to trigger stabilization of various transcripts, thereby causing large alterations in their abundance. We have previously shown that activation of the Wnt signaling pathway in pituitary alphaT3-1 cells induces a coordinate transcriptional and post-transcriptional regulation of select target genes        . We proposed that the integrated regulation of transcription and mRNA turnover is required to ensure rapid and relevant changes in the expression of regulatory genes       .
12	s1	N/A	0	Recently, we observed that a common set of transcripts is stabilized by either treatment with lithium chloride (LiCl), a mimicker of Wnt signaling     , or AKT activation in pituitary alphaT3-1 cells (unpublished data). Among these transcripts, we found beta-catenin. beta-catenin plays a key role in embryonic development and tumorigenesis by controlling the expression of Wnt-responsive genes        . In response to Wnt signals, Dishevelled is recruited to the Axin complex to inhibit glycogen synthase kinase-3beta, resulting in cytosolic accumulation and subsequent translocation of beta-catenin to the nucleus, where it binds to transcription factors of the T-cell factor/lymphoid enhancer factor family and transactivates Wnt target genes        . Serine/threonine kinases belonging to the AKT family are major effectors of the PI3K pathway and are activated by insulin and other polypeptide growth factors        . The recruitment of AKT to the plasma membrane by the lipid products of PI3K leads to AKT phosphorylation and activation        . Once activated, AKT exerts a central role in metabolism, cell survival, motility, transcription, and cell-cycle progression        . Cross-talks between Wnt and PI3K-AKT signaling pathways have been described        .
13	s1	N/A	0	In this report, we describe that beta-catenin mRNA is labile due to destabilizing elements located in its 3' UTR and that KSRP is a major molecular determinant of beta-catenin mRNA instability. beta-catenin transcript can be stabilized by either Wnt or PI3K-AKT signaling activation. AKT phosphorylates KSRP at a unique serine residue favoring its interaction with the adaptor protein 14-3-3. As a consequence, KSRP fails to interact with the exosome and, in turn, beta-catenin mRNA is stabilized.
15	s2	N/A	1	Results
17	s2a	N/A	1	beta-Catenin Is Encoded by a Labile mRNA Whose Half-Life Is Prolonged by Wnt Signaling
18	s2a	N/A	0	We previously reported that the treatment of mouse pituitary alphaT3-1 cells with LiCl (a compound widely used to mimic Wnt signaling     ) stabilizes select ARE-containing labile transcripts     . To identify additional ARE-containing transcripts whose mRNA t(1/2) is prolonged in alphaT3-1 cells in response to LiCl treatment, a large-scale analysis using the ARE-cDNA microarray system was performed     . The microarray screening revealed that LiCl treatment significantly upregulated, among others, beta-catenin mRNA (unpublished data). By both semiquantitative and quantitative RT-PCR, we confirmed that beta-catenin mRNA increased by approximately fourfold in cells treated with LiCl                                 . The inspection of mouse beta-catenin 3' UTR revealed the presence of several U-rich regions spread over the entire sequence (classified as class III AREs [28 and references cited therein]). As shown in         B, quantitative PCR experiments demonstrated that beta-catenin mRNA was unstable in intact alphaT3-1 cells displaying a t(1/2) of approximately 45 min, whereas the control beta2-microglobulin (beta2-MG) was stable. In order to verify whether beta-catenin AREs were responsible for the rapid decay of the endogenous transcript, we transfected alphaT3-1 cells with a reporter plasmid containing the entire beta-catenin 3' UTR placed at the 3' end of chloramphenicol acetyltransferase (CAT) sequence. As shown in         C, CAT-beta-catenin chimeric transcript displayed a short t(1/2) while control CAT mRNA was stable.
19	s2a	N/A	0	Next, we investigated whether Wnt signaling activation regulates beta-catenin mRNA turnover in intact cells. As shown in         D, LiCl treatment significantly prolonged the t(1/2) of beta-catenin mRNA while the t(1/2) of beta2-MG was unaffected. Furthermore, treatment of alphaT3-1 cells with recombinant mouse Wnt-3A increased beta-catenin mRNA steady-state levels            . Importantly, Wnt-3A treatment strongly prolonged beta-catenin t(1/2) in intact cells            .
20	s2a	N/A	0	These results suggest that beta-catenin mRNA is labile in unstimulated cells due to the presence of AREs in its 3' UTR. Wnt signaling activation stabilizes beta-catenin mRNA and induces its accumulation.
22	s2b	N/A	1	PI3K-AKT Activation Stabilizes beta-Catenin mRNA and Increases Both mRNA and Protein Steady-State Levels
23	s2b	N/A	0	As previously reported, besides mimicking the activation of the canonical Wnt pathway, LiCl also targets PI3K-AKT signaling        . Furthermore, the results of our ARE-cDNA microarray screening revealed that LiCl treatment and AKT activation, obtained expressing a constitutively active myristylated form of AKT1 (myrAKT1     ), induced stabilization of a common set of mRNAs including beta-catenin (unpublished data). These observations prompted us to investigate the effect of PI3K-AKT activation on beta-catenin mRNA turnover. First, we assessed the contribution given by PI3K-AKT pathway to LiCl-induced beta-catenin mRNA stabilization. We used both pharmacological inhibitors and an AKT dominant negative mutant [AKT1(K179M)] to block PI3K-AKT signaling. We found that treatment with either LY294002 (LY, a PI3K inhibitor     ) or triciribine (a specific AKT inhibitor     ) strongly reduced LiCl-induced stabilization of beta-catenin mRNA in intact alphaT3-1 cells                   . Similarly, AKT1(K179M) expression impaired LiCl-induced stabilization of beta-catenin mRNA in vitro            .
24	s2b	N/A	0	Next, we expressed myrAKT1 in alphaT3-1 cells. As shown in         D, the kinase activity immunoprecipitated with anti-AKT antibody was fivefold higher in alphaT3-1-myrAKT1 than in mock alphaT3-1 cells, thus demonstrating that active AKT kinase was present in extracts from cells expressing myrAKT1. The steady-state levels of beta-catenin mRNA were increased and beta-catenin mRNA t(1/2) was prolonged in alphaT3-1-myrAKT1 cells                   . myrAKT1 expression produced a similar stabilization of beta-catenin mRNA in murine C2C12 myoblasts (C2C12-myrAKT1,           . Importantly, we observed a strong increase of beta-catenin protein levels in both nuclear and cytosolic compartments of alphaT3-1-myrAKT1 and C2C12-myrAKT1 cells compared with control cells                                 .
25	s2b	N/A	0	These results suggest that PI3K-AKT activation stabilizes beta-catenin mRNA, leading to mRNA and protein accumulation.
27	s2c	N/A	1	Insulin-Induced PI3K-AKT Activation Stabilizes beta-Catenin mRNA and Increases Both mRNA and Protein Steady-State Levels
28	s2c	N/A	0	In order to verify whether insulin-induced AKT activation affects beta-catenin mRNA stabilization, we used insulin receptor-overexpressing HIRc-B rat cells, which display strong responses to insulin        . Indeed, the kinase activity immunoprecipitated with anti-AKT antibody was approximately sixfold higher in insulin-treated than in control HIRc-B cells, and LY treatment strongly reduced insulin-dependent AKT activation            .         B shows that insulin increased beta-catenin mRNA steady-state levels and that LY treatment almost completely blocked insulin effect. beta-catenin mRNA was significantly stabilized by insulin in intact HIRc-B cells, and LY treatment strongly decreased insulin-induced beta-catenin mRNA stabilization            . Accordingly, insulin induced beta-catenin protein accumulation in both cytosolic and nuclear fractions from HIRc-B cells            . To investigate whether insulin affects beta-catenin protein degradation rate, we treated HIRc-B cells with cycloheximide, to inhibit translational elongation, and monitored beta-catenin levels in total extracts after different intervals of time. As shown in         E, insulin did not affect the rate of beta-catenin protein decay.
29	s2c	N/A	0	In conclusion, a physiological activation of PI3K-AKT signaling causes stabilization of beta-catenin transcript and increases steady-state levels of both beta-catenin mRNA and protein.
31	s2d	N/A	1	The mRNA Destabilizing Factor KSRP Is Phosphorylated by AKT
32	s2d	N/A	0	We hypothesized that AKT activation stabilizes beta-catenin transcript by targeting the mRNA decay machinery. Among ARE-BPs known to affect mRNA turnover, only KSRP     and HuR      were able to specifically immunoprecipitate beta-catenin mRNA in RNA-immunoprecipitation experiments            . We first investigated whether AKT was able to phosphorylate either KSRP or HuR. KSRP was phosphorylated by recombinant purified AKT2 in vitro, whereas HuR was not phosphorylated            . In silico analysis (Motif Scan, http://scansite.mit.edu/motifscan_seq.phtml) of the human KSRP primary sequence performed at medium stringency indicated serine 193 (bold in the following peptide: GLPERSVSLTGAPES) as a potential AKT phosphorylation site (asterisk in         C, left). We evaluated the ability of AKT2 to phosphorylate KSRP deletion mutants expressed as GST-fusion proteins            . Only the KSRP fragments including KH1, where S193 is located, were phosphorylated by AKT2 in a concentration-dependent manner                                                        . Importantly, myrAKT1 expression enhanced the phosphorylation of coexpressed FLAG-KSRP while not affecting FLAG-KSRP(S193A) mutant, as shown by anti-FLAG immunoprecipitation following [32P]orthophosphate metabolic labeling of intact HeLa cells            . In order to unambiguously identify the KSRP residue(s) phosphorylated by AKT, recombinant human KSRP was phosphorylated by AKT2 in vitro, the gel band was digested with trypsin and enriched for phosphopeptides, and the peptides were analyzed by nanoflow liquid chromatography-tandem mass spectrometry (LC-MS/MS). This led to the identification of the unique peptide SV[pS]LTGAPESVQK with phosphorylation at the second serine residue (S193)            . The entire sequence of the phosphorylated peptide is perfectly conserved in several mammalian species (Mus musculus, Rattus norvegicus, Canis familiaris, and Bos taurus), and the phosphorylated serine is conserved, in a corresponding position, also in nonmammalian species (Gallus gallus, Xenopus laevis, and Danio rerio) (unpublished data). S193 was mutated to alanine in KH1-4 and KH1-2, and the mutant proteins were expressed in bacteria. As shown in         F, the S193A mutation abolished AKT-dependent phosphorylation in vitro.
33	s2d	N/A	0	Overall, these data suggest that AKT phosphorylates human KSRP at the unique site S193.
35	s2e	N/A	1	KSRP Controls beta-Catenin mRNA Turnover in alphaT3-1 Cells
36	s2e	N/A	0	The results presented above indicated that KSRP was phosphorylated by AKT and led us to hypothesize that KSRP could be involved in AKT-induced stabilization of beta-catenin mRNA. We and others demonstrated that KSRP regulates the stability of select mRNAs in response to different stimuli       . Thus, we investigated whether KSRP controls the decay rate of beta-catenin mRNA. Stable knock-down of KSRP obtained using shRNA in alphaT3-1 cells (alphaT3-1-shKSRP,         A) led to a more than fourfold increase of the steady-state levels of beta-catenin mRNA when compared to mock-transfected cells            . Furthermore, beta-catenin mRNA was stable in alphaT3-1-shKSRP in vivo             and in vitro             . Conversely, KSRP overexpression in alphaT3-1 cells blocked the LiCl-induced stabilization of beta-catenin mRNA             . Importantly, beta-catenin protein levels were approximately fourfold higher in alphaT3-1-shKSRP than in control cells, although beta-catenin protein decay rates were unchanged                   . The increase in beta-catenin expression was mirrored by an increase in luciferase activity driven by two beta-catenin-responsive reporters, TOP-FLASH and mouse c-myc promoter region            .
37	s2e	N/A	0	We ruled out the possibility that AKT activation could change KSRP expression levels affecting its protein stability. As shown in          , expression of myrAKT1 in alphaT3-1 cells did not affect either KSRP steady-state levels              or protein stability
38	s2e	N/A	0	Altogether, these results indicate that KSRP is crucial in controlling beta-catenin mRNA decay and, in turn, beta-catenin expression.
40	s2f	N/A	1	14-3-3 Interacts with Phosphorylated KSRP and Affects Its Decay-Promoting Activity
41	s2f	N/A	0	To investigate the functional consequences of KSRP phosphorylation by AKT, we performed in vitro reconstitution experiments. Either nonphosphorylated or AKT2-phosphorylated KSRP was added to S100 extracts from alphaT3-1-shKSRP in typical in vitro degradation assays. As presented in         , KSRP promoted rapid decay of beta-catenin mRNA, whereas AKT2-phosphorylated KSRP lacked its decay-promoting ability            . Similar results were obtained using KH1-4 as a GST fusion instead of the Baculovirus-expressed KSRP            . As predictable on the basis of the results shown in         F, the incubation of the mutant KH1-4(S193A) with AKT2 did not affect its beta-catenin RNA decay-promoting activity                         .
42	s2f	N/A	0	The sequence of the peptide including S193 closely resembles the phosphoserine-containing motif that is recognized by members of the 14-3-3 protein family     . Indeed, in a yeast two-hybrid screening performed in order to identify molecular partners of KSRP, we found, among others, the cDNA encoding 14-3-3zeta (unpublished data). To investigate whether phosphorylation by AKT favors the interaction of KSRP with 14-3-3, we cotransfected either myrAKT1 or the empty vector (mock) together with FLAG-KSRP     in 293T cells. The kinase activity immunoprecipitated by anti-AKT antibody was higher in myrAKT-293T than in mock 293T cells (unpublished data). Endogenous 14-3-3 coimmunoprecipitated with FLAG-KSRP only in cells transfected with myrAKT1            . Accordingly, GST-KH1-4 pulled down endogenous 14-3-3 present in extracts from alphaT3-1 cells stably expressing myrAKT1 but not from mock alphaT3-1 cells            . As predictable on the basis of the position of the unique AKT phosphorylation site (S193), only GST-KSRP fusion proteins containing the KH1 interacted with 14-3-3                                . We examined whether phosphorylated S193 is required for KSRP interaction with 14-3-3. Coimmunoprecipitation experiments showed that wild-type KSRP interacted with 14-3-3 when coexpressed with myrAKT1 in 293T cells, whereas KSRP(S193A) did not            . Accordingly, the S193A mutant KH1-4 [GST-KH1-4(S193A)] failed to interact with 14-3-3 in pull-down experiments (unpublished data). To inhibit the interaction between AKT-phosphorylated KSRP and 14-3-3, we used the synthetic peptide difopein, which binds to 14-3-3 proteins with high affinity and competitively inhibits 14-3-3-ligand interaction     . AKT2-phosphorylated KSRP was preincubated with either a scrambled peptide (control) or difopein, as indicated, before incubation with S100 extracts from alphaT3-1-shKSRP cells and used in in vitro RNA degradation experiments. Data presented in         E indicate that preincubation with difopein restored the decay-promoting activity of KH1-4, preventing the interaction of phosphorylated KH1-4 protein with 14-3-3            .
43	s2f	N/A	0	Altogether, our results indicate that AKT-phosphorylated KSRP interacts with 14-3-3 and that this interaction impairs the decay-promoting activity of KSRP in vitro.
45	s2g	N/A	1	AKT Activation Impairs the Interaction of KSRP with the Exosome
46	s2g	N/A	0	We investigated whether the impairment of the mRNA decay-promoting activity of KSRP upon phosphorylation by AKT2 (see         A) was due to either reduced RNA binding or reduced interaction with the decay machinery. In vitro phosphorylation by AKT2 did not affect the beta-catenin mRNA binding activity of KSRP either in the absence or in the presence of recombinant 14-3-3zeta                   .
47	s2g	N/A	0	Coimmunoprecipitation experiments performed in 293T cells showed that expression of myrAKT1 impaired the interaction of KSRP with core exosome components including hRrp4p and hRrp41 and with the exosome-associated factor hMtr4p                                      , whereas it did not affect the interaction with the deadenylase PARN. Similarly, in GST pull-down experiments, GST-KH1-4 interacted with hRrp4p and hMtr4p present in alphaT3-1 total extracts, whereas GST-KH1-4 phosphorylated in vitro by AKT2 failed to interact            . Difopein, competing the interaction between GST-KH1-4 and 14-3-3 (see         F), restored the ability of GST-KH1-4 to pull-down hRrp4p and hMtr4p            .
48	s2g	N/A	0	The evidence that myrAKT1 expression does not affect the interaction of KSRP with PARN prompted us to investigate whether beta-catenin mRNA deadenylation was affected by myrAKT1 expression in alphaT3-1 cells. As shown in in vitro degradation experiments presented in         F, deadenylated beta-catenin mRNA accumulated in alphaT3-1-myrAKT1 cells.
49	s2g	N/A	0	Our results suggest that phosphorylation by AKT and interaction with 14-3-3 affect the ability of KSRP to interact with the exosome.
51	s3	N/A	1	Discussion
52	s3	N/A	0	Here we report that beta-catenin is encoded by a labile transcript whose t(1/2) is prolonged by Wnt and PI3K-AKT signaling. The mRNA decay-promoting factor KSRP is required to ensure rapid degradation of beta-catenin transcript in unstimulated cells. AKT phosphorylates KSRP at a unique serine residue, creating a functional binding site for the molecular chaperone 14-3-3. As a consequence, AKT activation impairs KSRP ability to interact with the exoribonucleolytic complex exosome and, in turn, to promote rapid mRNA decay.
54	s3a	N/A	1	beta-Catenin mRNA Is Labile and Its Degradation Rate Is Controlled by the ARE-BP KSRP
55	s3a	N/A	0	With its involvement in the Wnt signal transduction pathway and tumorigenesis, beta-catenin is an extensively studied protein. However, the vast majority of studies focused on the control of beta-catenin protein degradation upon its signal-induced phosphorylation        . Lopez de Silanes et al.      identified beta-catenin mRNA as a target of the ARE-BP HuR in colon cancer cells, leading to the hypothesis that beta-catenin is encoded by a labile mRNA. Our results demonstrate that beta-catenin mRNA is labile in unstimulated cells and point to an unanticipated mechanism by which beta-catenin expression can be regulated at the level of its mRNA turnover by PI3K-AKT activation. Knock-down experiments demonstrate that KSRP controls the t(1/2) and the steady-state levels of beta-catenin mRNA, thus increasing beta-catenin protein levels and enhancing the beta-catenin-dependent TOP-FLASH- and c-myc promoter-dependent reporter transcription. Notably, KSRP knock-down did not affect beta-catenin protein degradation rate. While this manuscript was in preparation, a report from Thiele et al.      described the presence of alternative splicing in the 3' UTR of human beta-catenin mRNA that could influence its stability. However, we exclude that alternatively spliced isoforms exist in the 3' UTR of mouse beta-catenin mRNA in alphaT3-1 and C2C12 cells                                 . Surprisingly, Thiele et al.      reported that AREs in the 3' UTR of human beta-catenin mRNA are stabilizing elements. Our results indicate that beta-catenin transcript is unstable in four different cell lines (alphaT3-1, HIRc-B, C2C12 as presented in this report, and 293T, unpublished data) and that mouse beta-catenin 3' UTR confers instability to a reporter mRNA. These data are in agreement with the general view that AREs are destabilizing elements in unstimulated cells (reviewed in      ).
57	s3b	N/A	1	PI3K-AKT Activation Prolongs beta-Catenin mRNA Half-Life by Targeting KSRP
58	s3b	N/A	0	Our data suggest that PI3K-AKT signaling stabilizes beta-catenin transcript targeting the mRNA decay machinery. In the past, conflicting results on PI3K-AKT-induced control of beta-catenin protein degradation have been provided        . The discrepancies might depend on the divergent regulation of protein decay in different cell types. Indeed, we have observed that insulin-induced PI3K-AKT activation does not affect beta-catenin protein stability in HIRc-B cells            , while myrAKT1 expression slightly prolongs beta-catenin protein t(1/2) in alphaT3-1 cells (unpublished data). However, our results indicate that PI3K-AKT consistently induces beta-catenin mRNA stabilization and protein accumulation in both cell lines. Even though our data indicate that PI3K-AKT activation, regulating the mRNA decay machinery, can lead to beta-catenin protein accumulation in the absence of changes in its protein degradation rate, it is conceivable that an integrated control of both mRNA and protein stability could be required to ensure rapid and sustained changes of beta-catenin expression in response to certain proliferative and differentiative cues. Notably, AKT-induced interaction of beta-catenin protein with 14-3-3 has been shown to increase both beta-catenin levels and its transcriptional activity     . Therefore, AKT-dependent interaction of 14-3-3 either with a factor involved in beta-catenin mRNA turnover, such as KSRP, or with beta-catenin itself can lead to accumulation of beta-catenin protein. In a sense, 14-3-3 might be considered a biological switch controlling beta-catenin expression at different levels.
59	s3b	N/A	0	KSRP, a major regulator of beta-catenin mRNA decay, is phosphorylated by AKT at a unique residue (S193). It is a general concept that destabilizing ARE-BPs, including BRF1, KSRP, and TTP, are responsible for rapid decay of labile mRNAs in unstimulated cells recruiting the mRNA decay machinery      . We and others have previously shown that activation of the PI3K-AKT pathway controls the turnover of select mRNAs targeting either BRF1 or TTP and turning off their mRNA destabilizing function           . It is noteworthy that, in our experimental model, KSRP and HuR are the major ARE-BPs interacting with beta-catenin mRNA. PI3K-AKT activation does not affect the expression level and the phosphorylation status of HuR while inducing KSRP phosphorylation. It is possible to hypothesize that a certain signaling pathway can affect the turnover of select mRNAs regulating the function of distinct ARE-BPs, depending on the cellular context. On the other hand, the activation of different pathways can affect the turnover of different sets of transcripts targeting the same ARE-BP. In C2C12 myoblasts, MAPK p38 activation prolongs the t(1/2) of select myogenic transcripts inhibiting KSRP function    , whereas PI3K-AKT activation does not affect the stability of the same mRNAs (unpublished data). Similarly, p38 activation in alphaT3-1 cells does not affect the t(1/2) of beta-catenin mRNA (unpublished data). How the decay of distinct sets of transcripts can be specifically regulated by different signaling pathways that target the same ARE-BP is still an unsolved issue.
61	s3c	N/A	1	KSRP Interacts with 14-3-3 in a Serine 193-Dependent Way
62	s3c	N/A	0	Our data indicate that KSRP phosphorylation by PI3K-AKT creates a functional 14-3-3 binding site. Our current and previous findings, together with existing literature           , suggest that 14-3-3 family members play a regulatory role on the function of some destabilizing ARE-BPs.
63	s3c	N/A	0	Phosphorylation by AKT, followed by interaction with 14-3-3, impairs the ability of KSRP to promote beta-catenin mRNA decay, reducing KSRP interaction with the 3'-5' exoribonucleolytic complex exosome while leaving unaffected the ability of KSRP to interact with the mRNA. The results obtained using the high-affinity 14-3-3 competitor peptide difopein suggest that KSRP-14-3-3 interaction is implicated in this process. Unexpectedly, we found that AKT activation does not affect KSRP interaction with the deadenylase PARN and that deadenylated beta-catenin mRNA accumulates when incubated with S100 from alphaT3-1-myrAKT1 cells in in vitro degradation assays. We previously demonstrated that KSRP associates with mRNA decay enzymes, including PARN and the exosome components       . However, our recent data indicate that, although PARN is involved in the decay of a reporter mRNA by tethered KSRP, it does not appear to play a major role in the process while tethered KSRP primarily relies on exosome function    . Thus, our present results are in keeping with the idea that the exosome complex is the main enzymatic machine recruited by KSRP to the RNA    . It is noteworthy that a large-scale proteomic analysis identified three exosome components (hRrp4p, hRrp41p, and hRrp45) and the exosome-associated helicase hMtr4p, as well as KSRP itself, as molecular partners of 14-3-3     .
64	s3c	N/A	0	The four KH domains that constitute the central core of the KSRP are all necessary to ensure its interaction with the entire decay-promoting machinery    . S193 lies in the first KH domain of KSRP. Therefore, it is not surprising that the structural changes likely produced by phosphorylation, and the consequent interaction with 14-3-3, severely impair the beta-catenin mRNA decay-promoting function of KSRP.
65	s3c	N/A	0	In conclusion, the expression levels of beta-catenin have to be tightly regulated. As the amount of beta-catenin rises, it accumulates in the nucleus, where it interacts with specific transcription factors, leading to regulation of target genes. Inappropriate activation of the beta-catenin pathway is linked to a wide range of cancers, including colorectal cancer and melanoma. On the other hand, AKT has emerged as a crucial regulator of widely divergent cellular processes including apoptosis, differentiation, and metabolism. Disruption of normal AKT signaling has now been documented as a frequent occurrence in several human cancers, and it appears to play an important role in their progression. The results we obtained point to KSRP phosphorylation as a link between PI3K-AKT signaling and the control of beta-catenin mRNA t(1/2) and, consequently, of its expression. PI3K-AKT signaling activation, with consequent KSRP phosphorylation and functional deactivation, might contribute to sustain beta-catenin accumulation and, as a result, activation of target genes potentially able to accelerate tumor development.
67	s4	materials|methods	1	Materials and Methods
69	s4a	N/A	1	Reagents.
70	s4a	N/A	0	LY and insulin were obtained from Sigma (http://www.sigmaaldrich.com); triciribine, from Calbiochem/EMD Biosciences (http://www.emdbiosciences.com); Wnt-3A, from R&D Systems (http://www.rndsystems.com); and histone 2B, from Roche (http://www.roche.com).
72	s4b	N/A	1	Plasmids.
73	s4b	N/A	0	cDNA fragments containing mouse beta-catenin cDNA fragments (as shown in            and GAPDH 3' UTR (nucleotides 580-810) were subcloned into PstI-XbaI-restricted pCY2     . A cDNA fragment containing the coding region of human KSRP (nucleotides 202-2136) was cloned into the EcoRI-XhoI sites of pCMV-Tag2B vector (Stratagene, http://www.stratagene.com) in frame with the FLAG sequence to obtain a FLAG-KSRP plasmid. Mutagenesis was performed using FLAG-KSRP and the QuickChange Site-Directed Mutagenesis kit (Stratagene) to obtain FLAG-KSRP(S193A). HA-myrAKT1 cassette was excised from the plasmid previously described by Andjelkovic et al.      and subcloned into pcDNA3 (Invitrogen, http://www.invitrogen.com) to obtain pCMV-myr-AKT1, AKT1(K179M)      in pUSEamp plasmid, and TOP-FLASH expression vectors were from Upstate Biotechnology (http://www.upstate.com). Murine c-myc promoter (-1,100 +/- 580) fused with Luciferase was previously described     . To generate pCAT-beta-catenin 3' UTR, we cloned the entire mouse beta-catenin 3' UTR into the NotI-XbaI-restricted pcDNA3-CAT plasmid    .
75	s4c	N/A	1	Recombinant proteins and antibodies.
76	s4c	N/A	0	Affinity-purified human KSRP, expressed using the Baculovirus system, was described in Briata et al.    . GST-KSRP deletion mutants were previously described    . Amino acid 193 was mutagenized using the QuickChange Site-Directed Mutagenesis kit (Stratagene) to obtain GST-KH1-2(S193A) and GST-KH1-4(S193A), respectively. GST-14-3-3 plasmid was constructed cloning the entire coding sequence of mouse 14-3-3zeta into a pGEX vector.
77	s4c	N/A	0	Mouse monoclonal anti-14-3-3beta (K-19, which recognizes all the 14-3-3 family members), anti-14-3-3zeta (C-16, zeta-specific), anti-HuR monoclonal antibody 3A2, and anti-HDAC2 were obtained from Santa Cruz Biotechnology (http://www.scbt.com); mouse anti-GST was from Chemicon (http://www.chemicon.com); rabbit anti-AKT was from Cell Signaling (http://www.cellsignal.com); mouse anti-beta-catenin was from BD Transduction Laboratories (http://www.bdbiosciences.com); anti-KSRP antibody     was affinity purified and interacted with both human and rodent KSRP [4,14, and R. Gherzi, unpublished data]; and anti-hMtr4p      was generated against a hMtr4p(1-369)-GST fusion protein and affinity purified. Anti-AUF1 and anti-hnRNP-A1 were a gift from Dr. Gideon Dreyfuss (Howard Hughes Medical Institute), and anti-PARN, anti-hRrp41, anti-hRrp4p, and anti-TTP polyclonal antibodies were gifts from Drs. Elmar Wahle (University of Halle), Ger Pruijn (Nijmegen Center for Molecular Life Sciences), David Tollervey (Wellcome Trust Centre for Cell Biology), and William Rigby (Dartmouth Medical School), respectively. Anti-FLAG (M2), anti-alpha-tubulin, and anti-beta-actin monoclonal antibodies were from Sigma.
79	s4d	N/A	1	Cells and transfections.
80	s4d	N/A	0	Murine alphaT3-1 pituitary cells, rat HIRc-B fibroblasts, human HEK-293T cells (293T), and human HeLa cells were cultured in DMEM plus 10% FBS, and murine C2C12 myoblasts were cultured in DMEM plus 20% FBS. Cell transfections were performed using LipofectAMINE Plus (Invitrogen), and G418 (Invitrogen) was used at 500 to 800 mug/ml (depending on the cell line) for selection. Cell pools of transfectants were used for experiments. alphaT3-1 cells were starved in DMEM plus 0.5% FBS for 16 h prior to LiCl treatment, and alphaT3-1-myrAKT1 cells were starved in DMEM plus 0.5% FBS for 16 h prior to experiments. HIRc-B cells were starved in DMEM plus 0.1% FBS for 16 h prior to experiments or further treatments. Transient transfections of alphaT3-1 with either pcDNA3-CAT or pcDNA3-CAT-beta-catenin plasmids were performed as described in     with the exception that LipofectAMINE Plus was used.
82	s4e	N/A	1	Semiquantitative and quantitative RT-PCR.
83	s4e	N/A	0	Cells under different culture conditions were treated with 5 mug/ml actinomycin D and harvested at the indicated times, and total RNA was isolated using RNeasy Mini Kit (Qiagen, http://www.qiagen.com) and treated with DNase I (Promega, http://www.promega.com) according to the manufacturer's instructions. First-strand cDNA was obtained with Transcriptor Reverse Transcriptase (Roche).
84	s4e	N/A	0	For semiquantitative RT-PCR, 250 ng of total RNA was retrotranscribed using oligo-dT primer. beta2-MG was used as an internal control for normalizing transcripts levels measured by RT-PCR. To optimize RT-PCR, preliminary dose-response experiments were performed to determine the range of first-strand cDNA concentrations at which PCR amplification was linear for each target molecule essentially as reported in Briata et al.    . For each species of RNA analyzed, the amount of RT-PCR product (measured as densitometric units) was plotted against the input of first-strand cDNA.
85	s4e	N/A	0	For quantitative RT-PCR, 150 ng of DNase I-treated total RNA was retrotranscribed using random examers and PCRs were performed using the IQ Sybr Green Mix Super (Bio-Rad, http://www.bio-rad.com) and the MiniOpticon Real-Time PCR Detection System (Bio-Rad). The sequence-specific primers used for PCRs are listed in         .
87	s4f	N/A	1	RNA in vitro degradation and UV-crosslinking.
88	s4f	N/A	0	32P-labeled RNAs were synthesized and used as substrates for in vitro degradation assays as reported    . UV-crosslinking experiments were performed as described    .
90	s4g	N/A	1	Immunoprecipitation of ribonucleoprotein complexes.
91	s4g	N/A	0	Ribonucleoprotein complexes were immunoprecipitated from alphaT3-1 cell lysates as previously described    . Total RNA, extracted from either immunocomplexes or total cell lysates (input), was subjected to RT-PCRs. Primers are listed in         .
93	s4h	N/A	1	In vitro kinase assays and 32P orthophosphate metabolic labeling.
94	s4h	N/A	0	AKT (1 and 2) kinase assays were performed using preactivated enzymes purchased from Upstate Biotechnology (50 ng of the active enzyme/reaction) as recommended by manufacturer. [gamma-32P]ATP (3,000 Ci/mmol) was from Amersham Biosciences (http://www.amersham.com). In vivo 32P orthophosphate metabolic labeling of transiently transfected HeLa cells was performed as previously described     , incubating cells with orthophosphate for 16 h.
96	s4i	N/A	1	Isolation of phosphopeptides and LC-MS/MS and MS3 analysis.
97	s4i	N/A	0	Purified recombinant KSRP was phosphorylated by AKT2 in standard kinase assays. The reactions were analyzed by gel electrophoresis; bands were excised, digested with trypsin, and enriched for phosphopeptides using titanium dioxide microcolumns; and the peptides were analyzed by automated nanoflow LC-MS/MS with a method where the neutral loss of the phosphate group activate the acquisition of a second fragment ion spectrum (an MS3 spectrum) as previously described in detail     . All MS/MS spectra files from each LC run were centroided and merged to a single file, which was searched using the MASCOT search engine (Matrix Science, http://www.matrixscience.com) against the publicly available human database.
99	s4j	N/A	1	shRNA-mediated KSRP knock-down.
100	s4j	N/A	0	pSUPER-Puro-shKSRP was previously described    . alphaT3-1 cells were transfected using LipofectAMINE Plus (Invitrogen). Transfectant pools were selected with 0.3 mug/ml puromycin (Sigma).
102	s4k	N/A	1	Luciferase assays.
103	s4k	N/A	0	Transient transfections of either mock alphaT3-1 or alphaT3-1-shKSRP were carried out with LipofectAMINE Plus (Invitrogen). Luciferase activity was determined after 48 h with the Dual Luciferase System (Promega) following the indications of the manufacturer and using pRL-SV40 as a normalizing vector.
105	s5	supplementary-material	1	Supporting Information
107	supm-1	supm-1	1	beta-Catenin mRNA Is Stabilized by myrAKT1 Expression in Myoblasts C2C12
108	supm-1	supm-1	0	(A) In vitro RNA degradation assays using S100s from either mock C2C12 or C2C12 cells expressing myrAKT1. Internally 32P-labeled and capped RNA substrates were incubated with S100s for the indicated times, and their decay was analyzed as described in Materials and Methods.
109	supm-1	supm-1	0	(B) Semiquantitative RT-PCR analysis of beta-catenin mRNA in either mock C2C12 cells or C2C12 cells expressing myrAKT1. Total RNA was isolated as indicated after the addition of actinomycin D. The amount of each transcript was quantitated by densitometry and plotted using a linear regression program. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
110	supm-1	supm-1	0	(442 KB TIF)
111	supm-1	supm-1	0	Click here for additional data file.
113	supm-2	supm-2	1	KSRP Controls beta-Catenin mRNA Decay In Vitro
114	supm-2	supm-2	0	(A) In vitro RNA degradation assays using S100s from either mock-transfected (empty pSUPER-Puro vector) alphaT3-1 (mock alphaT3-1) or pSUPER-Puro-shKSRP-transfected alphaT3-1 cells (alphaT3-1-shKSRP).
115	supm-2	supm-2	0	(B) In vitro RNA degradation assays using S100s from either LiCl-treated mock-transfected alphaT3-1 cells or LiCl-treated FLAG-KSR-transfected alphaT3-1 cells. Internally 32P-labeled and capped RNA substrates were incubated with S100s for the indicated times, and their decay was analyzed as described in Materials and Methods.
116	supm-2	supm-2	0	(792 KB TIF)
117	supm-2	supm-2	0	Click here for additional data file.
119	supm-3	supm-3	1	Neither KSRP Steady-State Levels nor Protein Stability Is Affected by AKT1 Activation
120	supm-3	supm-3	0	(A) Immunoblot analysis of total extracts from the indicated cell lines with anti-KSRP and alpha-tubulin antibodies.
121	supm-3	supm-3	0	(B) Either mock alphaT3-1 or alphaT3-1-myrAKT1 cells were treated with cycloheximide (50 mug/ml) for the indicated times. Total cell extracts were prepared and the levels of KSRP were quantitated by immunoblotting and densitometric scanning. Results are the average (+/-SEM) of three experiments. alpha-Tubulin immunoblotting was used to verify the equal protein loading.
122	supm-3	supm-3	0	(341 KB TIF)
123	supm-3	supm-3	0	Click here for additional data file.
125	supm-4	supm-4	1	A Single mRNA Form Contains the Entire 3' UTR of Mouse beta-Catenin
126	supm-4	supm-4	0	RT-PCR analysis of total RNA from either mock alphaT3-1 cells (untreated or treated as indicated) or alphaT3-1-myrAKT1. The primers used are listed in          and schematically represented on the left.
127	supm-4	supm-4	0	(467 KB TIF)
128	supm-4	supm-4	0	Click here for additional data file.
130	supm-5	supm-5	1	Primers Used for RT-PCRs
131	supm-5	supm-5	0	The primers used for RT-PCRs were m-beta-catenin (mouse beta-catenin), m-AKT1 (mouse AKT1), r-beta-catenin (rat beta-catenin), b-C (the entire 3' UTR of mouse beta-catenin), m-beta2-MG (mouse beta2-MG), r-beta2-MG (rat beta2-MG), CAT; CAT-beta-catenin (the entire 3' UTR of mouse beta-catenin placed at the 3' of CAT), m-beta-cat Q-PCR (mouse beta-catenin for quantitative PCRs, and m-beta2-MG q-PCR (mouse beta2-MG for quantitative PCRs).
132	supm-5	supm-5	0	(35 KB DOC)
133	supm-5	supm-5	0	Click here for additional data file.
134	supm-4	supm-4	0	We are indebted to Drs. D. Tollervey, E. Wahle, G. Pruijn, G. Dreyfuss, W. Rigby, and A. Nicolin for reagents and antibodies.
135	supm-3	supm-3	1	Abbreviations
136	supm-2	supm-2	0	AU-rich element
137	supm-1	supm-1	0	ARE-binding proteins
138	s5	supplementary-material	0	chloramphenicol acetyltransferase
139	s4k	N/A	0	K homology
140	s4j	N/A	0	lithium chloride
141	s4i	N/A	0	liquid chromatography-tandem mass spectrometry
142	s4h	N/A	0	LY294002
143	s4g	N/A	0	beta2-microglobulin
144	s4f	N/A	0	myristylated form of AKT1
145	s4e	N/A	0	phosphatidylinositol 3-kinase
146	s4d	N/A	0	half-life
148	references	references	1	References
149	references	references	0	Wilusz CJ Wilusz J 2004 Bringing the role of mRNA decay in the control of gene expression into focus Trends Genet 20 491 497 15363903
151	references	references	0	Meyer S Temme C Wahle E 2004 Messenger RNA turnover in eukaryotes: Pathways and enzymes Crit Rev Biochem Mol Biol 39 197 216 15596551
153	references	references	0	Newbury SF 2006 Control of mRNA stability in eukaryotes Biochem Soc Trans 34 30 34 16246172
155	references	references	0	Gherzi R Lee KY Briata P Wegmuller D Moroni C 2004 A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery Mol Cell 14 571 583 15175153
157	references	references	0	Lykke-Andersen J Wagner E 2005 Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1 Genes Dev 19 351 361 15687258
159	references	references	0	Chou CF Mulky A Maitra S Lin WJ Gherzi R 2006 Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNA elicits mRNA decay Mol Cell Biol 26 3695 3706 16648466
161	references	references	0	Chen C-Y Gherzi R Andersen JS Gaietta G Jurchott K 2000 Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation Genes Dev 14 1236 1248 10817758
163	references	references	0	Frevel MA Bakheet T Silva AM Hissong JG Khabar KS 2003 p38 mitogen-activated protein kinase-dependent and independent signaling of mRNA stability of AU-rich element-containing transcripts Mol Cell Biol 23 425 436 12509443
165	references	references	0	Briata P Forcales SV Ponassi M Corte G Chen C-Y 2005 p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts Mol Cell 20 891 903 16364914
167	references	references	0	Dean JL Sully G Clark AR Saklatvala J 2004 The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation Cell Signal 16 1113 1121 15240006
169	references	references	0	Gaestel M 2006 MAPKAP kinases--MKs: Two's company, three's a crowd Nat Rev Mol Cell Biol 7 120 130 16421520
171	references	references	0	Ming X-F Stoecklin G Lu M Looser R Moroni C 2001 Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase Mol Cell Biol 21 5778 5789 11486017
173	references	references	0	Schmidlin M Lu M Leuenberger SA Stoecklin G Mallaun M 2004 The ARE-dependent mRNA destabilizing activity of BRF1 is regulated by protein kinase B EMBO J 23 4760 4769 15538381
175	references	references	0	Briata P Ilengo C Corte G Moroni C Rosenfeld MG 2003 The Wnt/beta-catenin>Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs Mol Cell 12 1201 1211 14636578
177	references	references	0	Kioussi C Briata P Baek SH Rose DW Hamblet NS 2002 Identification of a Wnt/Dvl/beta-catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development Cell 111 673 685 12464179
179	references	references	0	Hedgepeth CM Conrad LJ Zhang J Huang HC Lee VM 1997 Activation of the Wnt signaling pathway, a molecular mechanism for lithium action Dev Biol 185 82 91 9169052
181	references	references	0	Miller JR Moon RT 1996 Signal transduction through beta-catenin and specification of cell fate during embryogenesis Genes Dev 10 2527 2539 8895655
183	references	references	0	Cadigan KM Nusse R 1997 Wnt signaling, a common theme in animal development Genes Dev 11 3286 3305 9407023
185	references	references	0	Reya T Clevers H 2005 Wnt signalling in stem cells and cancer Nature 434 843 850 15829953
187	references	references	0	Fayard E Tintignac LA Baudry A Hemmings BA 2005 Protein kinase B/Akt at a glance J Cell Sci 118 5675 5678 16339964
189	references	references	0	Woodgett JR 2005 Recent advances in the protein kinase B signaling pathway Curr Opin Cell Biol 17 150 157 15780591
191	references	references	0	Whiteman EL Cho H Birnbaum MJ 2002 Role of Akt/protein kinase B in metabolism Trends Endocrinol Metab 13 444 451 12431841
193	references	references	0	Brazil DP Yang ZZ Hemmings BA 2004 Advances in protein kinase B signalling: AKTion on multiple fronts Trends Biochem Sci 29 233 242 15130559
195	references	references	0	Fukumoto S Hsieh CM Maemura K Layne MD Yet SF 2001 Akt participation in the Wnt signaling pathway through Dishevelled J Biol Chem 276 17479 17483 11278246
197	references	references	0	Desbois-Mouthon C Cadoret A Blivet-Van Eggelpoel MJ Bertrand F Cherqui G 2001 Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation Oncogene 20 252 259 11313952
199	references	references	0	Tian Q Feetham MC Tao WA He XC Li L 2004 Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt Proc Natl Acad Sci U S A 101 15370 15375 15492215
201	references	references	0	Almeida M Han L Bellido T Manolagas SC Kousteni S 2005 Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT J Biol Chem 280 41342 41351 16251184
203	references	references	0	Bakheet T Williams BR Khabar KS 2006 ARED 3.0: The large and diverse AU-rich transcriptome Nucleic Acids Res 34 D111 D114 16381826
205	references	references	0	Chalecka-Franaszek E Chuang DM 1999 Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons Proc Natl Acad Sci U S A 96 8745 8750 10411946
207	references	references	0	Sinha D Wang Z Ruchalski KL Levine JS Krishnan S 2005 Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors Am J Physiol Renal Physiol 288 F703 F713 15572521
209	references	references	0	Andjelkovic M Alessi DR Meier R Fernandez A Lamb NJ 1997 Role of translocation in the activation and function of protein kinase B J Biol Chem 272 31515 31524 9395488
211	references	references	0	Vlahos CJ Matter WF Hui KY Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) J Biol Chem 269 5241 5248 8106507
213	references	references	0	Yang L Dan HC Sun M Liu Q Sun XM 2004 Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt Cancer Res 64 4394 4399 15231645
215	references	references	0	McClain DA Maegawa H Lee J Dull TJ Ulrich A 1987 A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis J Biol Chem 262 14663 14671 3312193
217	references	references	0	Brennan CM Steitz JA 2001 HuR and mRNA stability Cell Mol Life Sci 58 266 277 11289308
219	references	references	0	Linker K Pautz A Fechir M Hubrich T Greeve J 2005 Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR Nucleic Acids Res 33 4813 4827 16126846
221	references	references	0	Yaffe MB Rittinger K Volinia S Caron PR Aitken A 1997 The structural basis for 14-3-3:phosphopeptide binding specificity Cell 91 961 971 9428519
223	references	references	0	Wang B Yang H Liu YC Jelinek T Zhang L 1999 Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display Biochemistry 38 12499 12504 10493820
225	references	references	0	Chen C-Y Gherzi R Ong SE Chan EL Raijmakers R 2001 AU binding proteins recruit the exosome to degrade ARE-containing mRNAs Cell 107 451 464 11719186
227	references	references	0	Lopez de Silanes I Fan J Yang X Zonderman AB Potapova O 2003 Role of the RNA-binding protein HuR in colon carcinogenesis Oncogene 22 7146 7154 14562043
229	references	references	0	Thiele A Nagamine Y Hauschildt S Clevers H 2006 AU-rich elements and alternative splicing in the beta-catenin 3' UTR can influence the human beta-catenin mRNA stability Exp Cell Res 312 2367 2378 16696969
231	references	references	0	Yuan H Mao J Li L Wu D 1999 Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation J Biol Chem 274 30419 30423 10521419
233	references	references	0	Ding VW Chen RH McCormick F 2000 Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling J Biol Chem 275 32475 32481 10913153
235	references	references	0	Haq S Michael A Andreucci M Bhattacharya K Dotto P 2003 Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth Proc Natl Acad Sci U S A 100 4610 4615 12668767
237	references	references	0	Segrelles C Moral M Lara MF Ruiz S Santos M 2006 Molecular determinants of Akt-induced keratinocyte transformation Oncogene 25 1174 1185 16247457
239	references	references	0	Marderosian M Sharma A Funk AP Vartanian R Masri J 2006 Tristetraprolin regulates cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling Oncogene 25 6277 6290 16702957
241	references	references	0	Chrestensen CA Schroeder MJ Shabanowitz J Hunt DF Pelo JW 2004 MK2 phosphorylates tristetraprolin on in vivo sites including S178, a site required for 14-3-3 binding J Biol Chem 279 10176 10184 14688255
243	references	references	0	Stoecklin G Stubbs T Kedersha N Wax S Rigby WF 2004 MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay EMBO J 23 1313 1324 15014438
245	references	references	0	Pozuelo Rubio M Geraghty KM Wong BH Wood NT Campbell DG 2004 14-3-3-Affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking Biochem J 379 395 408 14744259
247	references	references	0	Ramaswamy S Nakamura N Vazquez F Batt DB Perera S 1999 Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway Proc Natl Acad Sci U S A 96 2110 2115 10051603
249	references	references	0	Riggs KJ Saleque S Wong KK Merrell KT Lee JS 1993 Yin-yang 1 activates the c-myc promoter Mol Cell Biol 13 7487 7495 8246966
251	references	references	0	Gherzi R Russell DS Taylor SI Rosen OM 1987 Reevaluation of the evidence that an antibody to the insulin receptor is insulin mimetic without activating the protein tyrosine kinase activity of the receptor J Biol Chem 262 16900 16905 3680277
253	references	references	0	Gruhler A Olsen JV Mohammed S Mortensen P Faergeman NJ 2005 Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway Mol Cell Proteomics 4 310 327 15665377
256	sec-1	display-objects	1	Figures and Tables
258	fig-1	fig-1	1	mRNA Encoding beta-Catenin Is Labile and Is Stabilized by LiCl and Wnt-3A
259	fig-1	fig-1	0	(A) Expression of beta-catenin and beta2-MG (control transcript), monitored by RT-PCR, in control and in LiCl-treated (20 mM for 6 h) alphaT3-1 cells.
260	fig-1	fig-1	0	(B) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in alphaT3-1 cells. Total RNA was isolated at the indicated times after addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
261	fig-1	fig-1	0	(C) Quantitative RT-PCR analysis of both CAT and CAT-beta-catenin transcripts in either CAT or CAT-beta-catenin transiently transfected alphaT3-1 cells. Total RNA was isolated at the indicated times after addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
262	fig-1	fig-1	0	(D) Semiquantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in either control or LiCl-treated alphaT3-1 cells. Total RNA was isolated at the indicated times after the addition of actinomycin D. The amount of each transcript was quantitated by densitometry and plotted using a linear regression program. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
263	fig-1	fig-1	0	(E) Expression of beta-catenin and beta2-MG, monitored by RT-PCR, in either control-treated alphaT3-1, or Wnt-3A-treated (10 ng/ml, 6 h) alphaT3-1 cells.
264	fig-1	fig-1	0	(F) Semiquantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in either control or Wnt-3A-treated alphaT3-1 cells. Total RNA was isolated at the indicated times after the addition of actinomycin D. The amount of each transcript was quantitated and represented as described in (D).
266	fig-2	fig-2	1	PI3K-AKT Signaling Stabilizes beta-Catenin mRNA and Increases Its Expression
267	fig-2	fig-2	0	(A) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in alphaT3-1 cells treated with either DMSO (the solvent of LY, control), DMSO plus LiCl, or LY (25 muM for 16 h) plus LiCl. Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
268	fig-2	fig-2	0	(B) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in alphaT3-1 cells treated with either DMSO (the solvent of triciribine, control), DMSO plus LiCl (20 mM for 6 h), or triciribine (1 muM for 1 h) plus LiCl. Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
269	fig-2	fig-2	0	(C) In vitro RNA degradation assays using S100s from either LiCl-treated mock alphaT3-1 or LiCl-treated alphaT3-1 cells expressing the AKT dominant negative mutant AKT1(K179M) (alphaT3-1-AKTDN). Internally 32P-labeled and capped RNA substrates were incubated with S100s for the indicated times and their decay analyzed as described in Materials and Methods.
270	fig-2	fig-2	0	(D) Either mock alphaT3-1 or alphaT3-1-myrAKT1 cells were lysed and total extracts were immunoprecipitated (Ip) with either anti-AKT antibody or control IgG (cIgG). Pellets were incubated (20 min at 30 degreesC) with histone 2B (H2B) in kinase buffer in the presence of [gamma-32P]ATP. Labeled proteins were separated by SDS-PAGE and detected by autoradiography.
271	fig-2	fig-2	0	(E) Expression of beta-catenin and beta2-MG, monitored by RT-PCR, in either mock alphaT3-1 or alphaT3-1-myrAKT1 cells.
272	fig-2	fig-2	0	(F) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in either mock alphaT3-1 or alphaT3-1-myrAKT1 cells. Total RNA was isolated at the indicated times after addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
273	fig-2	fig-2	0	(G) Immunoblot analysis of either S100 or nuclear extracts from the indicated cell lines with anti- beta-catenin, alpha-tubulin, and HDAC2 antibodies.
275	fig-3	fig-3	1	Insulin Stabilizes beta-Catenin mRNA and Increases Its Expression
276	fig-3	fig-3	0	(A) HIRc-B cells were treated for 1 h with DMSO (control), insulin (10-6 M) plus DMSO, or LY (25 muM for 16 h) plus insulin. Total extracts were immunoprecipitated with either anti-AKT antibody or control IgG (cIgG). Pellets were incubated (20 min at 30 degreesC) with histone 2B (H2B) in kinase buffer in the presence of [gamma-32P]ATP. Labeled proteins were separated by SDS-PAGE and detected by autoradiography.
277	fig-3	fig-3	0	(B) Expression of beta-catenin and beta2-MG, monitored by RT-PCR, in control HIRc-B cells and in HIRc-B treated with either insulin or LY plus insulin.
278	fig-3	fig-3	0	(C) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in control HIRc-B cells, in HIRc-B treated with either insulin or LY plus insulin. Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
279	fig-3	fig-3	0	(D) Immunoblot analysis of either S100 or nuclear extracts from either control- or insulin-treated HIRc-B cells with anti-beta-catenin, beta-actin, and HDAC2 antibodies. The amount of each band was quantitated by densitometry and insulin was found to increase beta-catenin expression by 3.2- and 2.1-fold over the control in S100 and nuclear extracts, respectively.
280	fig-3	fig-3	0	(E) HIRc-B cells were maintained for 16 h in DMEM containing 0.1% FCS; then either PBS (control) or insulin (10-6 M) was added for 1 h. Cultures were then treated with cycloheximide (50 mug/ml) for the indicated times. Total cell extracts were prepared, and the levels of beta-catenin quantitated by immunoblotting and densitometric scanning. Results are the average (+/-SEM) of three experiments. beta-Actin immunoblotting was used to verify the equal protein loading.
282	fig-4	fig-4	1	KSRP Is Phosphorylated by AKT in Serine 193
283	fig-4	fig-4	0	(A) Immunoprecipitation of beta-catenin RNA-containing ribonucleoprotein complexes. The proteins were immunoprecipitated from alphaT3-1 total cell extracts using the indicated antibodies. RNA was extracted from the immune complexes and analyzed by RT-PCR as indicated.
284	fig-4	fig-4	0	(B) Either highly purified recombinant human KSRP (lanes 1 and 2) or affinity-purified GST-HuR (lanes 3 and 4) was incubated with either active recombinant AKT2 in kinase buffer or buffer alone in the presence of [gamma-32P]ATP. Labeled proteins were separated by SDS-PAGE, blotted to nylon membranes, and detected by autoradiography (top panel). Immunoblot analysis of the above kinase reactions with either anti-KSRP (middle panel) or anti-GST (bottom panel) antibodies.
285	fig-4	fig-4	0	(C) Schematic representation of KSRP and GST-fused deletion mutants. Asterisks indicate the position of a putative AKT phosphorylation site (left). AKT2 kinase assays were performed using the indicated recombinant protein substrates (middle and right). Arrows point to the position of each phosphorylated protein; the asterisk marks the position of phosphorylated AKT2.
286	fig-4	fig-4	0	(D) In vivo [32P]orthophosphate metabolic labeling of HeLa cells transiently cotransfected with either FLAG-KSRP plus empty pcDNA3, or FLAG-KSRP plus pCMV-myr-AKT1, or FLAG-KSRP(S193A) plus pCMV-myr-AKT1. Aliquots of the lysates were immunoprecipitated with protein A-protein G-Sepharose-bound mouse control IgG (cIgG) or anti-FLAG antibody, separated by SDS-PAGE, and autoradiographed (top panel). Immunoblot analysis of the above in vivo phosphorylation reactions with anti-FLAG antibody (bottom panel). Arrows point to the position of transfected KSRP.
287	fig-4	fig-4	0	(E) MS-MS fragmentation spectrum of the tryptic peptide SV[pS]LTGAPESVQK of KSRP showing phosphorylation of S193.
288	fig-4	fig-4	0	(F) AKT2 kinase assays using the indicated recombinant protein substrates. Arrows point to the position of each phosphorylated protein; the asterisk marks the position of phosphorylated AKT2.
290	fig-5	fig-5	1	KSRP Is Required for beta-Catenin mRNA Degradation
291	fig-5	fig-5	0	(A) Immunoblot analysis of total extracts from either mock alphaT3-1 (empty pSUPER-Puro vector-transfected) or alphaT3-1-shKSRP (pSUPER-Puro-shKSRP-transfected) cells using affinity-purified anti-KSRP and anti-alpha-tubulin antibodies.
292	fig-5	fig-5	0	(B) Expression of beta-catenin and beta2-MG, monitored by RT-PCR, in either mock alphaT3-1 or alphaT3-1-shKSRP cells.
293	fig-5	fig-5	0	(C) Quantitative RT-PCR analysis of both beta-catenin and beta2-MG transcripts in either mock alphaT3-1 or alphaT3-1-shKSRP cells. Total RNA was isolated at the indicated times after the addition of actinomycin D. The values shown are averages (+/-SEM) of three independent experiments performed in duplicate.
294	fig-5	fig-5	0	(D) Immunoblot analysis of total extracts from the indicated cell lines with anti-beta-catenin and alpha-tubulin antibodies.
295	fig-5	fig-5	0	(E) Either mock alphaT3-1 or alphaT3-1-shKSRP cells were treated with cycloheximide (50 mug/ml) for the indicated times. Total cell extracts were prepared and the levels of beta-catenin quantitated by immunoblotting and densitometric scanning. Results are the average (+/-SEM) of three experiments. alpha-Tubulin immunoblotting was used to verify the equal protein loading.
296	fig-5	fig-5	0	(F) Either mock alphaT3-1 or alphaT3-1-shKSRP cells were transiently transfected with either TOP-FLASH or c-myc-LUC reporter vectors, cultured for 2 d, and collected, and luciferase activity was measured. The values shown are averages (+/-SEM) of four independent experiments performed in duplicate.
298	fig-6	fig-6	1	KSRP Phosphorylation by AKT Promotes Its Interaction with 14-3-3 and Affects Its mRNA-Destabilizing Function
299	fig-6	fig-6	0	(A) In vitro RNA degradation assays using S100s from either mock alphaT3-1 (lanes 1-4) or alphaT3-1-shKSRP cells (lanes 5-28) preincubated with BSA (lanes 1-8), GST (lanes 17-20), KSRP (30 nM, lanes 9-12), AKT2-phosphorylated KSRP (30 nM, lanes 13-16), KH1-4 (S193A) (30 nM, lanes 21-24), or AKT2-phosphorylated KH1-4(S193A) (30 nM, lanes 25-28), respectively. Internally 32P-labeled and capped RNA substrates were added, and their decay was monitored as described above.
300	fig-6	fig-6	0	(B) Coimmunoprecipitation of FLAG-KSRP and endogenous 14-3-3 in 293T cells transiently transfected with FLAG-KSRP and either pCMV empty vector (mock 293T) or pCMV-myrAKT1 (293T-myrAKT1). Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using anti-14-3-3 antibody.
301	fig-6	fig-6	0	(C) GST pull-down of endogenous 14-3-3 from total extracts of either mock alphaT3-1 (lanes 1-3) or alphaT3-1-myrAKT1 (lanes 4-11) cells using either control GST, GST-KH1-4, or the additional KSRP deletion mutants fused with GST (as indicated, see         B for a schematic representation of KSRP deletion mutants). Proteins were analyzed by immunoblotting using anti-14-3-3 antibody.
302	fig-6	fig-6	0	(D) Coimmunoprecipitation of either FLAG-KSRP or FLAG-KSRP(S193A) and endogenous 14-3-3 in 293T cells transiently transfected with pCMV-myrAKT1 (293T-myrAKT1) and either FLAG-KSRP or FLAG-KSRP(S193A). Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using anti-14-3-3 antibody.
303	fig-6	fig-6	0	(E) In vitro RNA degradation assays using S100s from alphaT3-1-shKSRP cells pre-incubated with either GST (lanes 1-4), KH1-4 (30 nM, lanes 5-8), AKT2-phosphorylated KH1-4 (30 nM, lanes 9-12), or AKT2-phosphorylated KH1-4 (30 nM) preincubated with difopein (50 nM) (lanes 13-16), respectively. Internally 32P-labeled and capped RNA substrates were added, and their decay monitored was as described above.
304	fig-6	fig-6	0	(F) GST pull-down of endogenous 14-3-3 from total extracts of alphaT3-1-myrAKT1 cells using either control GST, GST-KH1-4, or GST-KH1-4 preincubated with 50 nM difopein (as indicated). Proteins were analyzed by immunoblotting using anti-14-3-3 antibody.
306	fig-7	fig-7	1	AKT Activation Affects KSRP-Exosome Interaction
307	fig-7	fig-7	0	(A) The interaction between 32P-labeled ARE beta-catenin RNA and recombinant purified KSRP (increasing amounts from 30 to 300 nM) subjected to kinase reactions in the absence or in the presence of AKT2 (as indicated) was evaluated by UV-crosslinking.
308	fig-7	fig-7	0	(B) The interaction between 32P-labeled ARE beta-catenin RNA and recombinant purified KSRP (50 nM) subjected to AKT2 phosphorylation in the presence of either GST (50 nM) or GST-14-3-3 (50 nM, as indicated) was evaluated by UV-crosslinking.
309	fig-7	fig-7	0	(C) Coimmunoprecipitation of FLAG-KSRP and either endogenous exosome components (hRrp4p and hMtr4p, as indicated) or endogenous deadenylase PARN in 293T cells transiently transfected with FLAG-KSRP and either pCMV empty vector (mock-293T) or pCMV-myrAKT1 (293T-myrAKT1). Cell lysates were immunoprecipitated as indicated and analyzed by immunoblotting using the indicated antibodies.
310	fig-7	fig-7	0	(D) GST pull-down of endogenous hRrp4p and hMtr4p from total extracts of alphaT3-1 cells using GST-KH1-4 subjected to kinase reaction either in the absence or in the presence of AKT2. Proteins were analyzed by immunoblotting using the indicated antibodies. Asterisks indicate antibody cross-reactivity with GST-fusion proteins.
311	fig-7	fig-7	0	(E) GST pull-down of endogenous hRrp4p and hMtr4p from total extracts of alphaT3-1-myrAKT1 cells using either control GST, GST-KH1-4, or GST-KH1-4 preincubated with 50 nM difopein (as indicated). Proteins were analyzed by immunoblotting using either anti-hRrp4p or anti-hMtr4p antibodies.
312	fig-7	fig-7	0	(F) In vitro RNA degradation assays using S100s from either mock alphaT3-1 or alphaT3-1-myrAKT1 cells. Internally 32P-labeled, capped, and polyadenylated beta-catenin and GAPDH RNA substrates were incubated with S100s for the indicated times, and their decay was analyzed as described in Materials and Methods. Arrows point to either poly(A)+ or poly(A)- beta-catenin RNA species.
313	fig-6	fig-6	0	Author contributions. RG and PB conceived and designed the experiments. RG, MT, MP, TR, KSK, JSA, and PB performed the experiments. RG, MT, KSK, JSA, and PB analyzed the data. GC, CM, and CYC contributed reagents/materials/analysis tools. RG, MT, and PB wrote the paper.
314	fig-5	fig-5	0	Funding. This work has been partly supported by grants from Associazione Italiana Ricerca sul Cancro, AIRC (to RG), Fondazione Telethon (GGP04012), and Istituto Superiore di Sanita (526/A30) (to PB).
315	fig-4	fig-4	0	Competing interests. The authors have declared that no competing interests exist.
